Galenica Group has bolstered the portfolio of its Verfora Swiss consumer healthcare operation by acquiring for an undisclosed sum Dr. Wild & Co.’s pharmaceuticals business.
Galenica Grows In Switzerland With Dr. Wild OTC Portfolio
Galenica has acquired an OTC portfolio from Switzerland's Dr. Wild, led by the market leading vitamin D supplements Vitamin D3 Wild Oil and VI-DE 3, which generated sales of CHF19m in 2020.
